Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

GSK plc Sponsored ADR(GSK US)

$50.45+0.260.52%Ext:$51.79+1.342.65%(Market Closed · 01:00:04 UTC)
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
CategorizedChronologicalBy Owner

Financials & Metrics

FinancialsChartingShort InterestEmployees
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

GSK plc Sponsored ADR(GSK US)

$50.45+0.260.52%Ext:$51.79+1.342.65%(Market Closed · 01:00:04 UTC)
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
CategorizedChronologicalBy Owner

Financials & Metrics

FinancialsChartingShort InterestEmployees
GSK US​
Ask AI
GSK US​
Ask AI

SEC Filings by Owner

SEC Filings by Owner

Insider Ownership

GSK Plc(132)

  • Form 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP15 Dec 2025
  • Form 4WVE - CHANGE IN BENEFICIAL OWNERSHIP1 Oct 2024
  • Form 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP30 Jan 2024
  • Form 3INITIAL STATEMENT OF BENEFICIAL OWNERSHIP30 Jan 2023
  • Form 3Initial statement of beneficial ownership14 Nov 2022
  • Form 4Statement of changes in beneficial ownership16 Sep 2022
  • Form 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP6 Jul 2021
  • Form 3INITIAL STATEMENT OF BENEFICIAL OWNERSHIP6 Jul 2021
  • Form 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES23 Jun 2021
  • Form 3ME - INITIAL STATEMENT OF BENEFICIAL OWNERSHIP4 Nov 2022

SMITHKLINE BEECHAM CORP(2)

  • Form 4MAIN DOCUMENT DESCRIPTION14 Jul 2005
  • Form 3Initial statement of beneficial ownership3 May 2005

S R ONE(2)

  • Form 4Statement of changes in beneficial ownership12 Apr 2004
  • Form 3Initial statement of beneficial ownership6 Apr 2004

≥5% Ownership

GSK Plc(189)

  • SC 13D/ACureVac N.V.5 Dec 2025
  • SC 13DCureVac N.V.13 Aug 2025
  • SC 13D/ASpero Therapeutics, Inc.28 Mar 2025
  • SC 13D/A23andMe Holding Co.15 Nov 2024
  • SC 13G/AGSK plc12 Nov 2024
  • SC 13D/ANkarta, Inc.28 Mar 2024
  • SC 13D/A23andMe Holding Co.9 Feb 2024
  • SC 13G/ACureVac N.V.6 Feb 2024
  • SC 13G/AWave Life Sciences Ltd.6 Feb 2024
  • SC 13D/AHaleon plc19 Jan 2024

BlackRock Inc.(13)

  • SC 13G/AGlaxosmithkline Plc7 Feb 2022
  • SC 13G/AGlaxosmithkline Plc29 Jan 2021
  • SC 13G/AGlaxosmithkline Plc5 Feb 2020
  • SC 13G/AGlaxosmithkline Plc4 Feb 2019
  • SC 13G/AGlaxosmithkline Plc30 Jan 2018
  • SC 13G/AGlaxosmithkline Plc24 Jan 2017
  • SC 13G/AGlaxosmithkline Plc26 Jan 2016
  • SC 13G/AGlaxosmithkline Plc30 Jan 2015
  • SC 13G/AGlaxosmithkline Plc11 Feb 2014
  • SC 13G/AGlaxosmithkline Plc8 Feb 2013

DODGE & COX(4)

  • SC 13G/AGSK plc13 Aug
  • SC 13G/AGSK plc13 Feb 2024
  • SC 13G/AGsk Plc14 Feb 2023
  • SC 13GGlaxosmithkline Plc14 Feb 2022

FMR LLC(1)

  • SC 13GGSK plc6 May

BlackRock, Inc.(1)

  • SC 13G/AGSK plc7 Mar 2025

Insider Ownership

GSK Plc(132)

  • Form 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP15 Dec 2025
  • Form 4WVE - CHANGE IN BENEFICIAL OWNERSHIP1 Oct 2024
  • Form 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP30 Jan 2024
  • Form 3INITIAL STATEMENT OF BENEFICIAL OWNERSHIP30 Jan 2023
  • Form 3Initial statement of beneficial ownership14 Nov 2022
  • Form 4Statement of changes in beneficial ownership16 Sep 2022
  • Form 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP6 Jul 2021
  • Form 3INITIAL STATEMENT OF BENEFICIAL OWNERSHIP6 Jul 2021
  • Form 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES23 Jun 2021
  • Form 3ME - INITIAL STATEMENT OF BENEFICIAL OWNERSHIP4 Nov 2022

SMITHKLINE BEECHAM CORP(2)

  • Form 4MAIN DOCUMENT DESCRIPTION14 Jul 2005
  • Form 3Initial statement of beneficial ownership3 May 2005

S R ONE(2)

  • Form 4Statement of changes in beneficial ownership12 Apr 2004
  • Form 3Initial statement of beneficial ownership6 Apr 2004

≥5% Ownership

GSK Plc(189)

  • SC 13D/ACureVac N.V.5 Dec 2025
  • SC 13DCureVac N.V.13 Aug 2025
  • SC 13D/ASpero Therapeutics, Inc.28 Mar 2025
  • SC 13D/A23andMe Holding Co.15 Nov 2024
  • SC 13G/AGSK plc12 Nov 2024
  • SC 13D/ANkarta, Inc.28 Mar 2024
  • SC 13D/A23andMe Holding Co.9 Feb 2024
  • SC 13G/ACureVac N.V.6 Feb 2024
  • SC 13G/AWave Life Sciences Ltd.6 Feb 2024
  • SC 13D/AHaleon plc19 Jan 2024

BlackRock Inc.(13)

  • SC 13G/AGlaxosmithkline Plc7 Feb 2022
  • SC 13G/AGlaxosmithkline Plc29 Jan 2021
  • SC 13G/AGlaxosmithkline Plc5 Feb 2020
  • SC 13G/AGlaxosmithkline Plc4 Feb 2019
  • SC 13G/AGlaxosmithkline Plc30 Jan 2018
  • SC 13G/AGlaxosmithkline Plc24 Jan 2017
  • SC 13G/AGlaxosmithkline Plc26 Jan 2016
  • SC 13G/AGlaxosmithkline Plc30 Jan 2015
  • SC 13G/AGlaxosmithkline Plc11 Feb 2014
  • SC 13G/AGlaxosmithkline Plc8 Feb 2013

DODGE & COX(4)

  • SC 13G/AGSK plc13 Aug
  • SC 13G/AGSK plc13 Feb 2024
  • SC 13G/AGsk Plc14 Feb 2023
  • SC 13GGlaxosmithkline Plc14 Feb 2022

FMR LLC(1)

  • SC 13GGSK plc6 May

BlackRock, Inc.(1)

  • SC 13G/AGSK plc7 Mar 2025